(Q33781669)

29 July 2017

1 reference

title

Strategies for the management of diabetic dyslipidaemia (English)

1 reference

29 July 2017

1 reference

Taskinen MR

1

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58 Suppl 1

1 reference

29 July 2017

page(s)

47-51; discussion 75-82

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958001-00011

29 July 2017

exact match

0 references

cites work

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

12 December 2020

Hyperlipidaemia of diabetes

1 reference

12 December 2020

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

Triglyceride is the major atherogenic lipid in NIDDM.

1 reference

12 December 2020

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

12 December 2020

1 reference

12 December 2020

Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients

1 reference

12 December 2020

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

1 reference

12 December 2020

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

12 December 2020

The biochemistry of diabetes

1 reference

12 December 2020

Hyperlipidaemia in diabetes

1 reference

12 December 2020

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

1 reference

12 December 2020

The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project

1 reference

12 December 2020

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

12 December 2020

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

12 December 2020

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

1 reference

12 December 2020

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

1 reference

12 December 2020

Diabetes and atherosclerosis: an epidemiologic view

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

12 December 2020

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

12 December 2020

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II

1 reference

12 December 2020

Lipoprotein metabolism in diabetes mellitus

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

12 December 2020

10.2165/00003495-199958001-00011

Identifiers

DOI

0 references

Dimensions Publication ID

1006495797

0 references

1 reference